Inna Belfer, MD PhDNIH Pain Consortium

Dr. Belfer is a world-recognized expert in human pain genetics and phenomics. She began her career as a neurologist, then received extensive training in neurobiology and human genetics. Her primary research interests have been the relationship between gene polymorphisms and complex phenotypes such as pain, psychiatric disorders, and addictions. Her research focused on biobehavioral aspects of acute and chronic pain, sex influence on pain and analgesia, and genomic predictors of the transformation of acute pain into chronic condition. After serving as a Staff Scientist at National Institutes of Health (NIH) Intramural Pain Program, she joined the University of Pittsburgh as Associate Professor of Anesthesiology and Human Genetics and the Director of the Molecular Epidemiology of Pain Program. In 2015, Dr. Belfer joined the Food and Drug Administration as a medical officer for novel analgesics, evaluating clinical trial design and safety data, and analyzed trends and new scientific fields to assess the adequacy of clinical translational pain research including sex-specific factors controlling pain. Dr. Belfer has returned to NIH to direct the extramural pain portfolio at the National Center for Complementary and Integrative Health.